Revyve Antimicrobial Skin and Wound Cleanser

Revyve Antimicrobial Skin and Wound Cleanser is a specialized wound care solution developed by Kane Biotech. It received U.S. FDA 510(k) clearance in February 2026 for the mechanical cleansing, debridement, and removal of foreign materials, including microorganisms and biofilms, from a variety of acute and chronic wounds. The product is indicated for use on Stage I-IV pressure ulcers, diabetic foot ulcers, venous ulcers, postsurgical wounds, and burns. As part of the revyve platform, the cleanser is designed to address the challenges of wound biofilms, which are known to delay healing and contribute to antimicrobial resistance. The formulation leverages technology engineered to effectively clean the wound bed and maintain a moist environment conducive to healing.

Brand names

Revyve Antimicrobial Skin and Wound Cleanser

Other names

Kane Biotech Wound Cleanser